Filing Details
- Accession Number:
- 0001209191-18-046800
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-15 16:27:04
- Reporting Period:
- 2018-08-14
- Accepted Time:
- 2018-08-15 16:27:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1685071 | Dova Pharmaceuticals Inc. | DOVA | Pharmaceutical Preparations (2834) | 813858961 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1709415 | Alex Sapir | C/O Dova Pharmaceuticals, Inc. 240 Leigh Farm Road, Suite 245 Durham NC 27707 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-14 | 21,700 | $22.83 | 21,700 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 46,909 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.65 - 23.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
- The reportable securities are owned directly by Alexander C. Sapir Revocable Trust (the "Trust"). The Reporting person is the trustee of the Trust.